• Korean Journal of Radiology
• /
• 제20권8호
• /
• pp.1285-1292
• /
• 2019

Objective: To evaluate the safety and efficacy of the coil-protected technique for liquid embolization in neurovascular malformations. Materials and Methods: Twenty-two patients who underwent coil-protected liquid embolization for symptomatic cranial (n = 13) and spinal (n = 9) arteriovenous fistula (AVF) or arteriovenous malformations (AVMs) were identified. A total of 36 target feeder vessels were embolized with N-butyl cyanoacrylate and/or Onyx (Medtronic). This technique was used to promote delivery of a sufficient amount of liquid embolic agent into the target shunt or nidus in cases where tortuous feeding arteries preclude a microcatheter wedging techniqu and/or to prevent reflux of the liquid embolic agent in cases with a short safety margin. The procedure was considered technically successful if the target lesion was sufficiently filled with liquid embolic agent without unintentional reflux. Angiographic and clinical outcomes were retrospectively evaluated. Results: Technical success was achieved for all 36 target feeders. Post-embolization angiographies revealed complete occlusion in 16 patients and near-complete and partial occlusion in three patients each. There were no treatment-related complications. Of the six patients who showed near-complete or partial occlusion, five received additional treatments: two received stereotactic radiosurgery for cerebral AVM, two underwent surgical removal of cerebral AVM, and one underwent additional embolization by direct puncture for a mandibular AVM. Finally, all patients showed complete (n = 19) or near-complete (n = 3) occlusion of the target AVF or AVM on follow-up angiographies. The presenting neurological symptoms improved completely in 15 patients (68.2%) and partially in seven patients (31.8%). Conclusion: The coil-protected technique is a safe and effective method for liquid embolization, especially in patients with various neurovascular shunts or malformations who could not be successfully treated with conventional techniques.

• Korean Journal of Radiology
• /
• 제24권2호
• /
• pp.145-154
• /
• 2023

Objective: We aimed to evaluate the efficacy of EmboTrap II in terms of first-pass recanalization and to determine whether it could yield favorable outcomes. Materials and Methods: In this multicenter, prospective study, we consecutively enrolled patients who underwent mechanical thrombectomy using EmboTrap II as a front-line device. The primary outcome was the first pass effect (FPE) rate defined by modified Thrombolysis In Cerebral Infarction (mTICI) grade 2c or 3 by the first pass of EmboTrap II. In addition, modified FPE (mFPE; mTICI grade 2b-3 by the first pass of EmboTrap II), successful recanalization (final mTICI grade 2b-3), and clinical outcomes were assessed. We also analyzed the effect of FPE on a modified Rankin Scale (mRS) score of 0-2 at 3 months. Results: Two hundred-ten patients (mean age ± standard deviation, 73.3 ± 11.4 years; male, 55.7%) were included. Ninety-nine patients (47.1%) had FPE, and mFPE was achieved in 150 (71.4%) patients. Successful recanalization was achieved in 191 (91.0%) patients. Among them, 164 (85.9%) patients underwent successful recanalization by exclusively using EmboTrap II. The time from groin puncture to FPE was 25.0 minutes (interquartile range, 17.0-35.0 minutes). Procedure-related complications were observed in seven (3.3%) patients. Symptomatic intracranial hemorrhage developed in 14 (6.7%) patients. One hundred twenty-three (58.9% of 209 completely followed) patients had an mRS score of 0-2. Sixteen (7.7% of 209) patients died during the follow-up period. Patients who had successful recanalization with FPE were four times more likely to have an mRS score of 0-2 than those who had successful recanalization without FPE (adjusted odds ratio, 4.13; 95% confidence interval, 1.59-10.8; p = 0.004). Conclusion: Mechanical thrombectomy using the front-line EmboTrap II is effective and safe. In particular, FPE rates were high. Achieving FPE was important for an mRS score of 0-2, even in patients with successful recanalization.

• Journal of Korean Neurosurgical Society
• /
• 제64권2호
• /
• pp.297-308
• /
• 2021

Objective : Shunt infection is a common complication while treating hydrocephalus. The antibiotic-impregnated shunt catheter (AISC) was designed to reduce shunt infection rate. A meta-analysis was conducted to study the effectiveness of AISCs in reduction of shunt infection in terms of age, follow-up time and high-risk patient population. Methods : This study reviewed literature from three databases including PubMed, EMBASE, and Cochrane Library (from 2000 to March 2019). Clinical studies from controlled trials for shunt operation were included in this analysis. A subgroup analysis was performed based on the patient's age, follow-up time and high-risk population. The fixed effect in RevMan 5.3 software (Cochrane Collaboration) was used for this meta-analysis. Results : This study included 19 controlled clinical trials including 10105 operations. The analysis demonstrated that AISC could reduce the infection rate in shunt surgery compared to standard shunt catheter (non-AISC) from 8.13% to 4.09% (odds ratio [OR], 0.48; 95% confidence interval [CI], 0.40-0.58; p=0.01; I2=46%). Subgroup analysis of different age groups showed that AISC had significant antimicrobial effects in all three groups (adult, infant, and adolescent). Follow-up time analysis showed that AISC was effective in preventing early shunt infections (within 6 months after implant). AISC is more effective in high-risk population (OR, 0.24;95% CI, 0.14-0.40; p=0.60; I2=0%) than in general patient population. Conclusion : The results of meta-analysis indicated that AISC is an effective method for reducing shunt infection. We recommend that AISC should be considered for use in infants and high-risk groups. For adult patients, the choice for AISC could be determined based on the treatment cost.

• 대한영상의학회지
• /
• 제84권2호
• /
• pp.441-453
• /
• 2023

목적 네 가지 방법으로 토끼의 뇌에 VX2 세포를 이식하여 뇌종양의 생성 유무와 위치, 체적을 분석하고자 한다. 대상과 방법 공여 토끼를 희생하여 얻은 VX2 세포 현탁액을 1) 당일 이식, 2) 냉장 보관 7일 후 이식, 3) 초저온 냉동보관 7일 후 이식, 그리고 4) 공여 토끼를 희생하지 않고 조직생검 기구를 이용하여 VX2 세포현탁액을 얻은 후 당일 이식하였다. 뇌 이식에는 정위 기구를 사용하였으며 하방 레버를 이용하여 5 mm 진입하여 VX2 세포 현탁액을 주입하였다. 10일 경과 후 MR imaging을 실시하였으며 다음 날 뇌 조직을 얻어 조직검사를 실시하여 MR 영상과 현미경 검사상 뇌종양의 생성 유무와 위치, 체적 등을 살펴보았다. 결과 VX2 세포 현탁액을 당일 이식한 토끼(n = 18)에서는 17마리(94.4%)에서 뇌종양이 생겼다(평균 체적은 106.32 mm³). 냉장 보관 후 7일에 세포 현탁액을 만들어 뇌 이식한 토끼(n = 5)에서는 1마리(20%)에서 뇌종양이 생겼으나 현미경으로만 확인되었다. 초저온 냉동 보관 후 7일에 세포 현탁액을 만들어 뇌 이식한 토끼는 5마리에서는 3마리(60%)에서 뇌종양이 생겼고 현미경으로만 확인되었다. 생검 횟수를 10회 실시한 후 이식한 3마리에서는 뇌종양이 생기지 않았고, 20회 실시한 후 이식한 2마리에서는 모두 뇌종양이 생겼으며 MR 영상과 조직검사에서 확인되었다(평균 체적 38.71 mm³). 네 가지 방법으로 발생한 종양의 위치는 superficial cortex가 대부분이었다. 결론 VX2 세포를 이식하여 토끼의 뇌종양 모델을 제작하는 기법은 쉽고 재현성은 다양했다. 이 모델은 뇌종양에 대한 영상, 치료 방법, 중재 시술 및 약물 전달 등 다양한 연구에 활용될 수 있을 것이다. 연구자의 처한 다양한 환경에 따라 다양한 방법으로 VX2 세포를 이식할 수 있을 것으로 생각된다.